Telinavir

Star0

DB12178InvestigationalSmall molecule

Telinavir has been used in trials studying the treatment of HIV Infections.

Mechanism: Pharmacologically active on HIV-1 retropepsin
Curator reviewed
Formula / weight: C₃₃H₄₄N₆O₅ · 604.752 g/mol (avg)

Resolves to

Compound

UNIIIZF55EH3CGCAS143224-34-4ChEMBLCHEMBL322241PubChem382974

Structure

InChIKeyZILOOGIOHVCEKS-HZFUHODCSA-NSMILESCC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(N)=O)NC(=O)C1=CC=C2C=CC=CC2=N1)C(=O)NC(C)(C)C

Targets

Q72874polP03366gag-pol

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Telinavir, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account